Nicola Gullick
Nicola Gullick
Consultant Rheumatologist, University Hospitals Coventry & Warwickshire
Adresse e-mail validée de nhs.net
Titre
Citée par
Citée par
Année
In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses
HG Evans, NJ Gullick, S Kelly, C Pitzalis, GM Lord, BW Kirkham, ...
Proceedings of the National Academy of Sciences 106 (15), 6232-6237, 2009
2102009
Interleukin‐17+ CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression
B Menon, NJ Gullick, GJ Walter, M Rajasekhar, T Garrood, HG Evans, ...
Arthritis & rheumatology 66 (5), 1272-1281, 2014
1972014
Co-morbidities in established rheumatoid arthritis
NJ Gullick, DL Scott
Best practice & research Clinical rheumatology 25 (4), 469-483, 2011
1482011
TNF-α blockade induces IL-10 expression in human CD4+ T cells
HG Evans, U Roostalu, GJ Walter, NJ Gullick, KS Frederiksen, ...
Nature communications 5 (1), 1-12, 2014
892014
Linking power Doppler ultrasound to the presence of Th17 cells in the rheumatoid arthritis joint
NJ Gullick, HG Evans, LD Church, DM Jayaraj, A Filer, BW Kirkham, ...
PloS one 5 (9), e12516, 2010
892010
Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127low regulatory T cells
GJ Walter, HG Evans, B Menon, NJ Gullick, BW Kirkham, AP Cope, ...
Arthritis & Rheumatism 65 (3), 627-638, 2013
792013
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
J Ledingham, N Gullick, K Irving, R Gorodkin, M Aris, J Burke, P Gordon, ...
Rheumatology 56 (6), 865-868, 2017
602017
Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis
NJ Gullick, HS Abozaid, DM Jayaraj, HG Evans, DL Scott, EH Choy, ...
Clinical & Experimental Immunology 174 (2), 292-301, 2013
582013
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
A Tjärnlund, Q Tang, C Wick, M Dastmalchi, H Mann, JT Studýnková, ...
Annals of the rheumatic diseases 77 (1), 55-62, 2018
482018
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise
T Bharucha, A Rutherford, S Skeoch, A Alavi, M Brown, J Galloway, ...
Clinical radiology 72 (9), 764-771, 2017
342017
Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
I Al-Shakarchi, NJ Gullick, DL Scott
Patient preference and adherence 7, 653, 2013
342013
An examination of work instability, functional impairment, and disease activity in employed patients with rheumatoid arthritis
A Macedo, S Oakley, N Gullick, B Kirkham
The Journal of rheumatology 36 (2), 225-230, 2009
342009
FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+ CD25− responder T cells, but not CD4+ CD25+ regulatory T cells
AL Jagger, HG Evans, GJ Walter, NJ Gullick, B Menon, LE Ballantine, ...
Journal of autoimmunity 38 (1), 29-38, 2012
232012
Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound
AN Mian, K Chaabo, J Wajed, S Subesinghe, NJ Gullick, B Kirkham, ...
BMC musculoskeletal disorders 17 (1), 404, 2016
192016
Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years
NJ Gullick, SP Oakley, A Zain, T Gibson, T Jones, A Mistlin, JD Rees, ...
Rheumatology 51 (4), 759-761, 2012
182012
Patient involvement in rheumatology outpatient service design and delivery: a case study
S de Souza, J Galloway, C Simpson, R Chura, J Dobson, NJ Gullick, ...
Health Expectations 20 (3), 508-518, 2017
142017
Drug therapy of inflammatory arthritis
NJ Gullick, DL Scott
Clinical medicine 12 (4), 357, 2012
122012
A synovial pathergy reaction leading to a pseudo-septic arthritis and a diagnosis of Behçet's disease
F Humby, N Gullick, S Kelly, C Pitzalis, SP Oakley
Rheumatology 47 (8), 1255-1256, 2008
122008
Clinical utility of the RAID (RA impact of disease) score
NJ Gullick, DL Scott
Nature Reviews Rheumatology 7 (9), 499-500, 2011
102011
Failure of adalimumab in patients with rheumatoid arthritis
N Gullick, C Da Silva, B Kirkham
Arthritis Rheum 56 (suppl), S183, 2007
62007
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20